AI is now embedded in how organisations invent, draft, search and market but much of what GenAI touches may be difficult to protect or enforce if you don't set clear guardrails. Explore how to are use AI in patent and brand work while still "owning the win".
You understand the value of your IP portfolio, but boards think in growth, risk, capital allocation and return on investment. How can you reframe IP as a business asset, influence investment decisions and communicate value in terms that resonate with CEOs, CFOs and investors?
No organisation has the resources to investigate every seller, remove every listing or pursue every infringement. As counterfeit networks become more sophisticated and enforcement costs continue to rise, brand protection teams must make difficult decisions about where investment will deliver the greatest business impact. Join your peers to discuss how leading organisations prioritise enforcement, allocate budgets and demonstrate value beyond takedown volumes.
Counterfeiters are not all playing the same game as your brand protection function. Explore how understanding who is targeting your brand, how their illicit supply chain operates and which enforcement actions disrupt their business can help brand protection teams move beyond activity-based metrics and create greater impact.
In 2027, brand protection teams are not only fighting counterfeits in courts and marketplaces, they're enlisting their customers as a line of defence. By combining product authentication and education campaigns, they're helping consumers recognise genuine products, report suspicious ones and avoid unsafe goods. Explore how to pair consumer education and enforcement with prevention, so your customers actively help protect your brand, strengthen trust and improve product safety.
GenAI, cloud platforms, SaaS tools and globally connected workforces now hold a huge share of your trade secrets. Information is finding new ways of escaping from these systems. And the leak is not always a hacker. Often, it is a capable employee under deadline pressure, a partner with entirely legitimate credentials, or an access grant that outlived the project it was created for. Drawing on recent decisions, including 2026 rulings on AI tools, confidentiality and the evidence courts expect to see.
M&A, funding rounds and IPOs put IP portfolios under intense scrutiny, often surfacing issues that have built up over years of acquisitions, reorganizations and inconsistent portfolio hygiene. Your peers describe deals slowing over messy ownership chains, unclear rights in collaborations, weak trade secret practice and portfolios that aren't clearly tied to products and revenue. We'll discuss what buyers, investors and auditors are really looking for, and how to spot and fix hidden IP risks before they become deal breakers.